港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

抗疫概念

934.624

+20.5422.25%

漲家數：16

跌家數：2

平家數：- -

市盈率：- -

高：939.018

開：916.307

低：913.204

收：914.082

資料載入中...

總覽新聞資訊

京東健康發起罕見病關愛行動聯合倡議攜手各方共建患者服務生態

康希諾：mRNA技術平臺可應用於多類生物製品的開發，包括腫瘤領域及免疫治療也可以是拓展方向

康希諾：公司DTcP-Hib-MCV4聯合疫苗產品在臨牀方案中已對相關免疫程序的最新適配予以考慮

攜手大疆推出全球首款車載無人機，比亞迪銷量大漲

君實生物2024年虧損收窄，研發投入三年縮減超50%

新華製藥獲批成為“硫酸氫氯吡格雷片 ”上市許可持有人

山東新華製藥股份(00719)收到硫酸氫氯吡格雷片《藥品補充申請批准通知書》

中國生物製藥03月03日獲主力加倉652萬元

汽車行業動態報告：繼續看好整車板塊關注智駕及機器人調整買點

中信建投证券股...

福蓉科技：公司主要向比亞迪供應鋁製結構件材料

比亞迪電子(00285)下跌5.09%，報47.55元/股

出行+飛行，又多了個買比亞迪的理由？

君實生物盤中異動股價大跌5.05%報14.280港元

1.6 萬元！比亞迪推出史上最貴配件

醫院邁入AI時代，AI醫療概念再度活躍，低迷醫藥股開啓反彈上漲

京東健康－Ｒ(86618)股價上升5.873%，現價 $33.35

阿斯达克财经

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1515/news?page=29"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":934.62427,"timestamp":1741939708687,"preClose":914.0818,"halted":0,"volume":403022060,"delay":0,"changeRate":0.022473,"change":20.54248,"pbRate":1.683293,"amount":3250148824,"amplitude":0.02824,"prevYearClose":787.97723,"fiveDayClose":938.742,"twentyDayClose":968.201,"turnoverRate":0.005247,"marketCap":647341368064,"floatMarketCap":530519208960,"peRate":20.153696},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":939.01776,"amplitude":0.02824,"preClose":914.0818,"low":913.2039,"pbRate":"1.683293","latestPrice":934.62427,"volume":403022060,"delay":0,"open":916.30707,"prevYearClose":787.97723,"prevWeekClose":938.742,"prevMonthClose":904.791,"prevQuarterClose":787.977,"fiveDayClose":938.742,"twentyDayClose":968.201,"sixtyDayClose":828.289,"secType":"PLATE","market":"HK","turnoverRate":0.005247,"peRate":20.153696,"marketCap":647341368064,"floatMarketCap":530519208960,"timestamp":1741939708687,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":16,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:16,pageCount:29,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516682841","title":"京東健康發起罕見病關愛行動聯合倡議 攜手各方共建患者服務生態","url":"https://stock-news.laohu8.com/highlight/detail?id=2516682841","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516682841?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 19:11","pubTimestamp":1741000290,"startTime":"0","endTime":"0","summary":"本报讯（记者袁传玺）2月28日，2025年国际罕见病日当日，京东健康股份有限公司（以下简称“京东健康”）联合人民日报健康客户端在京举办了第四届罕见病服务生态论坛。会上，京东健康联合北京爱力重症肌无力罕见病关爱中心、北京东方丝雨渐冻人罕见病关爱中心、北京病痛挑战公益基金会、雀巢健康科学，以及北京新光公益发展中心，共同发起主题为“罕见之光·携手聚力”的罕见病关爱行动联合倡议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503033334972633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1591","BK1589","LU0456827905.SGD","BK1142","06618","BK1247","86618","BK1571","BK1515","LU0051755006.USD","BK1583"],"gpt_icon":0},{"id":"2516868398","title":"康希諾：mRNA技術平臺可應用於多類生物製品的開發，包括腫瘤領域及免疫治療也可以是拓展方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2516868398","media":"互动易","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516868398?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 17:09","pubTimestamp":1740992941,"startTime":"0","endTime":"0","summary":"有投资者向康希诺提问， 贵公司上海康希诺的定位是什么？疫苗+药品是公司唯一壮大的途径，上海康希诺未来是否向创新肿瘤药和创新免疫药方面发展？谢谢。公司回答表示，尊敬的投资人您好，康希诺上海子公司主要为mRNA技术等前沿技术的探索与技术积累转化而设立。mRNA技术平台可应用于多类生物制品的开发，包括肿瘤领域及免疫治疗也可以是拓展方向。现阶段公司将在做好主营业务的基础上进行延展探索。未来如有阶段性进展，将及时分享。谢谢！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303171942a25cddb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303171942a25cddb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","BK1161","06185","BK1515","688185"],"gpt_icon":0},{"id":"2516683985","title":"康希諾：公司DTcP-Hib-MCV4聯合疫苗產品在臨牀方案中已對相關免疫程序的最新適配予以考慮","url":"https://stock-news.laohu8.com/highlight/detail?id=2516683985","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516683985?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 17:09","pubTimestamp":1740992940,"startTime":"0","endTime":"0","summary":"有投资者向康希诺提问， 请问贵公司一个问题，贵公司的全球创新品种五联苗获批临床，但问题是贵公司的三组分百白破疫苗2月龄开打，Hib免疫程序也是2月龄开打，但奇怪的是贵公司的四价流脑结合疫苗是三月龄开打，那么问题来了，贵公司五联苗是2月龄开打还是3月龄开打？如果是3月龄开打，又有何竞争优势？再者贵公司的五联大概什么时候开始临床？谢谢。公司回答表示，尊敬的投资人您好，感谢您的关注及专业提问。公司DTcP-Hib-MCV4联合疫苗产品在临床方案中已对相关免疫程序的最新适配予以考虑，并结合产品未来在市场端的竞争优势进行布局。目前该候选产品尚处于临床前准备阶段，如有阶段性进展，将及时分享。谢谢！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303171955abe5cd60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303171955abe5cd60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","BK1191","06185","BK1574","688185"],"gpt_icon":0},{"id":"2516110637","title":"攜手大疆推出全球首款車載無人機，比亞迪銷量大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2516110637","media":"金色光","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516110637?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 16:53","pubTimestamp":1740992025,"startTime":"0","endTime":"0","summary":"近日，新能源汽车行业龙头比亚迪与无人机行业领军企业深圳大疆共同发布全球首款车载无人机系统“灵鸢”。在上述新能源汽车智能化技术推动之下，2025年前两月，比亚迪汽车销量同比大涨92.52%。“高性价比+全系智驾+无人机”，比亚迪销量爆发比亚迪已经处于全球新能源汽车行业领先地位。公司是2023年和2024年全球新能源汽车销量冠军。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231016abe64007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303231016abe64007&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015978.USD","BK1580","LU0979878070.USD","LU0289739343.SGD","BK1607","LU2348774022.SGD","LU0289960550.SGD","81211","LU2097828805.USD","LU0164872284.USD","01211","BK1149","LU0516422440.USD","LU2778985437.USD","HYDD.SI","SG9999015952.SGD","LU1242518931.SGD","LU0320764599.SGD","BK1594","LU2097828631.EUR","LU0143863198.USD","SG9999006514.SGD","LU0516423174.USD","002594","BYDDY","00285","LU0175139822.USD","BK1610","LU0417516738.SGD","LU0449515922.USD","LU0516423091.SGD","LU0511384066.AUD","LU1861214812.USD","LU0214875030.USD","SG9999006597.SGD","SG9999015945.SGD","LU0254981946.USD","LU2097828557.USD","BK1522","LU0052750758.USD","LU2476274308.USD","LU0819121731.USD","BK1515","LU0359201612.USD","LU0823414478.USD","BK1504","LU0516422952.EUR","LU0593848301.USD","LU0823426480.USD","LU2360107325.USD"],"gpt_icon":1},{"id":"2516893500","title":"君實生物2024年虧損收窄，研發投入三年縮減超50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516893500","media":"新京报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516893500?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 16:51","pubTimestamp":1740991876,"startTime":"0","endTime":"0","summary":"君实生物上周公布的2024年业绩快报显示，报告期内在营收同比增长29.67%的同时，亏损额收窄至12.82亿元，为近三年最低水平，君实生物将营收上涨归因于旗下药品的销售增长。近年来，君实生物也在优化资源配置，聚焦于更有潜力的管线，随之而来便是“大砍”研发投入。截至2024年前三季度，君实生物研发投入为8.74亿元，而在2023年同期，这一数字为12.71亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503033334827966.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503033334827966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1515","BK1583","01877"],"gpt_icon":0},{"id":"2516500055","title":"新華製藥獲批成為“硫酸氫氯吡格雷片 ”上市許可持有人","url":"https://stock-news.laohu8.com/highlight/detail?id=2516500055","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516500055?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 16:44","pubTimestamp":1740991464,"startTime":"0","endTime":"0","summary":"新华制药发布公告，近日，公司收到国家药品监督管理局核准签发的硫酸氢氯吡格雷片《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。据悉，硫酸氢氯吡格雷片为循环系统疾病药物，系一种前体药物，其代谢产物之一是血小板聚集抑制剂。硫酸氢氯吡格雷片于2025年2月通过国家药品监督管理局审批，新华制药成为本品的上市许可持有人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303165527a25cd460&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303165527a25cd460&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","00719","BK1515"],"gpt_icon":0},{"id":"2516023635","title":"山東新華製藥股份(00719)收到硫酸氫氯吡格雷片《藥品補充申請批准通知書》","url":"https://stock-news.laohu8.com/highlight/detail?id=2516023635","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516023635?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 16:32","pubTimestamp":1740990730,"startTime":"0","endTime":"0","summary":"智通财经APP讯，山东新华制药股份(00719)发布公告，近日，该公司收到国家药品监督管理局核准签发的硫酸氢氯吡格雷片(以下简称“本品”)《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。公告称，硫酸氢氯吡格雷片于2025年2月通过国家药品监督管理局审批，新华制药成为本品的上市许可持有人。该产品的上市，有利于丰富公司循环系统药物产品线，提升公司综合竞争优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","00719","BK1515"],"gpt_icon":0},{"id":"2516500063","title":"中國生物製藥03月03日獲主力加倉652萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516500063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516500063?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 16:15","pubTimestamp":1740989737,"startTime":"0","endTime":"0","summary":"03月03日, 中国生物制药股价跌0.62%，报收3.20元，成交金额2.14亿元，换手率0.35%，振幅4.04%，量比0.55。中国生物制药今日主力资金净流入652万元，连续4日净流入，上一交易日主力净流入138万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为44.44%，平均涨幅为2.91%。该股近5个交易日下跌7.58%，主力资金累计净流入4028万元；近20日主力资金累计净流入3960万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303165241abe5c251&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303165241abe5c251&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","BK1521","01177","BK1589"],"gpt_icon":0},{"id":"2516950699","title":"汽車行業動態報告：繼續看好整車板塊 關注智駕及機器人調整買點","url":"https://stock-news.laohu8.com/highlight/detail?id=2516950699","media":"中信建投证券股...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516950699?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 15:40","pubTimestamp":1740987633,"startTime":"0","endTime":"0","summary":"继续看好整车板块，关注智驾及机器人调整买点?本周智驾、机器人板块调整幅度较大，在基本面未有明显利空情况下，板块回调或因股价高位下获利资金兑现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030315404896372761&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030315404896372761&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2476274308.USD","BK1539","SG9999015986.USD","LU0823426480.USD","SG9999006514.SGD","BYDDY","LU0143863198.USD","002594","LU0708995583.HKD","601633","81211","LU1868837565.USD","LU0175139822.USD","LU0819123356.HKD","LU0348805143.USD","BK1607","LU0516422440.USD","LU0516422366.SGD","02333","GWLLY","LU2249611893.SGD","LU0516423091.SGD","LU0289961442.SGD","LU0856984785.SGD","LU0289960550.SGD","LU0359201612.USD","LU1242518931.SGD","BK1589","00285","BK1504","HYDD.SI","LU0211977185.USD","01211","LU0320764599.SGD","LU0417516738.SGD","LU1861219969.SGD","SG9999006597.SGD","BK1515","00175","IE00BD6J9T35.USD","LU0307460666.USD","LU0274383008.USD","LU0214875030.USD","LU0143863784.USD","82333","LU0531970944.HKD","LU0359202008.SGD","LU2097828631.EUR","LU2097828557.USD","LU0348767384.USD","LU0979878070.USD"],"gpt_icon":1},{"id":"2516990506","title":"福蓉科技：公司主要向比亞迪供應鋁製結構件材料","url":"https://stock-news.laohu8.com/highlight/detail?id=2516990506","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516990506?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 15:36","pubTimestamp":1740987369,"startTime":"0","endTime":"0","summary":"有投资者向福蓉科技提问， 董秘您好：贵公司产品有供应比亚迪？公司回答表示，你好！比亚迪是公司重要客户之一，双方已经合作多年。公司主要向比亚迪供应铝制结构件材料，经比亚迪加工后用于手机、平板电脑、笔记本电脑等消费电子终端品牌产品。谢谢关注！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303154607abe5a4e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303154607abe5a4e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0143863784.USD","BK1515","BK1607","LU0348805143.USD","LU1242518857.USD","IE00BD6J9T35.USD","LU0819123356.HKD","LU0143863198.USD","LU0175139822.USD","BK1539","LU0359201612.USD","SG9999006514.SGD","LU1242518931.SGD","BK1589","HYDD.SI","BK1580","LU1868837565.USD","LU0320764599.SGD","LU0417516738.SGD","SG9999015986.USD","002594","LU0516422440.USD","LU0307460666.USD","LU1861219969.SGD","LU0516423091.SGD","BK1504","LU0214875030.USD","LU0211977185.USD","LU0289960550.SGD","00285","LU0289961442.SGD","LU2097828631.EUR","LU2249611893.SGD","SG9999006597.SGD","LU0274383008.USD","LU2097828557.USD","LU0708995583.HKD","01211","LU0516422366.SGD","LU0531970944.HKD","LU0856984785.SGD","LU1861214812.USD","LU0359202008.SGD","LU0823426480.USD","LU0348767384.USD","81211","LU0052750758.USD","LU2476274308.USD","BYDDY","LU0979878070.USD"],"gpt_icon":0},{"id":"2516707105","title":"比亞迪電子(00285)下跌5.09%，報47.55元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2516707105","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516707105?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 14:41","pubTimestamp":1740984060,"startTime":"0","endTime":"0","summary":"3月3日，比亚迪电子(00285)盘中下跌5.09%，截至14:41，报47.55元/股，成交13.31亿元。比亚迪电子(国际)有限公司是一家全球领先的平台型高端制造企业，主要提供新材料开发、产品设计与研发、零部件及整机制造、供应链管理、物流及售后等一站式服务。公司的业务主要涵盖智能手机、平板电脑、新能源汽车、智能家居、游戏硬件、无人机、物联网、机器人、通信设备、医疗健康等多元化市场领域。截至2024年中报，比亚迪电子营业总收入785.81亿元、净利润15.18亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/03144148480955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","LU0274383008.USD","BK1504","BK1582","BK1540","BK1580","BK1589","BK1607","00285","LU0348766576.USD","BK1149","LU0348767384.USD"],"gpt_icon":0},{"id":"2516393570","title":"出行+飛行，又多了個買比亞迪的理由？","url":"https://stock-news.laohu8.com/highlight/detail?id=2516393570","media":"银柿财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516393570?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 14:30","pubTimestamp":1740983435,"startTime":"0","endTime":"0","summary":"3月2日，比亚迪携手大疆，在深圳举办了智能车载无人机系统发布会，并将该系统正式定名为“灵鸢”，持续加速智能化布局。据悉，无人机系统是由无人机以及相关地面系统、任务载荷和控制链路等组成的复杂空地系统。比亚迪旗下全品牌搭载灵鸢此次，比亚迪和大疆的携手，从无人机着手切入低空经济领域，既是产品层面的深入合作，也是出行场景生态的全新构建。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303143051a25c9993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303143051a25c9993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01211","LU1023057109.AUD","LU2249611893.SGD","LU0588546209.SGD","LU0516422952.EUR","SG9999015978.USD","SG9999002463.SGD","BK1149","BK1515","LU0254981946.USD","LU2097828805.USD","LU0819121731.USD","LU0175139822.USD","LU1868837722.USD","LU0143863198.USD","LU2476274308.USD","BK1504","LU0348735423.USD","LU1868838027.USD","LU0359201612.USD","LU2097828631.EUR","LU0348805143.USD","002594","LU1868837565.USD","SG9999014674.SGD","BK1607","LU0531970944.HKD","LU2153592121.USD","LU0516422366.SGD","LU2360107325.USD","00285","LU0307460666.USD","LU0823414478.USD","LU0359202008.SGD","BK1539","IE00BD6J9T35.USD","LU1861219969.SGD","LU1861214812.USD","LU0289960550.SGD","BYDDY","LU0593848301.USD","BK1119","BK1582","81211","BK1540","LU2348774022.SGD","LU0320764599.SGD","LU0823426308.USD","LU0819123356.HKD","HYDD.SI"],"gpt_icon":1},{"id":"2516703535","title":"君實生物盤中異動 股價大跌5.05%報14.280港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516703535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516703535?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 14:27","pubTimestamp":1740983269,"startTime":"0","endTime":"0","summary":"2025年03月03日下午盘14时27分，君实生物股票出现波动，股价快速跳水5.05%。截至发稿，该股报14.280港元/股，成交量236.84万股，换手率1.08%，振幅7.71%。资金方面，该股资金流入1079.17万港元，流出1782.84万港元。君实生物股票所在的生物技术行业中，整体跌幅为1.83%。“PD-1四小龙”中，君实生物与其他三家的竞争不在同一维度。君实生物披露业绩快报同日，百济神州也公布了过去一年的经营数据。关键的是，“PD-1四小龙”中仅君实生物的营收重度依赖PD-1产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030314275096371274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030314275096371274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01877","688180","BK1161","BK1583"],"gpt_icon":0},{"id":"2516577046","title":"1.6 萬元！比亞迪推出史上最貴配件","url":"https://stock-news.laohu8.com/highlight/detail?id=2516577046","media":"爱范儿","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516577046?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 14:09","pubTimestamp":1740982188,"startTime":"0","endTime":"0","summary":"昨晚，比亚迪集团董事长兼总裁王传福在发布会上宣布，比亚迪和大疆共同研发的智能车载无人机系统正式命名为“灵鸢”。▲仰望 U8 越野玩家版的车载无人机在去年 1 月举办的 2024 比亚迪梦想日上，比亚迪就携手大疆推出了全球首个整车集成的车载无人机。“经过了一年的仰望 U8 用户反馈和技术的融合，如今比亚迪站在 2025 年的新起点，推出了灵鸢。”其中，方程豹豹 8 无人机版已经在昨晚的发布会里正式上市，起售价为 39.58 万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8hQBhlkVBrc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["LU1242518857.USD","LU1808992512.USD","81211","LU2249611893.SGD","LU0823426480.USD","LU0588546209.SGD","LU0175139822.USD","LU0289961442.SGD","BK0183","LU2348774022.SGD","HYDD.SI","BK1515","LU0823414478.USD","LU2778985437.USD","LU2580892789.USD","LU0819123356.HKD","LU0052750758.USD","LU1781817850.SGD","LU0348767384.USD","SG9999015978.USD","EVS.SI","LU0516422952.EUR","LU0593848301.USD","LU0819121731.USD","LU0143863784.USD","LU0214875030.USD","LU2097828557.USD","00285","BK1539","BK0169","LU1868837565.USD","BK1504","LU0531970944.HKD","LU0320764599.SGD","LU0979878070.USD","BYDDY","BK0014","LU0449509016.USD","LU1023057109.AUD","BK0264","LU1820825898.SGD","LU0708995583.HKD","SG9999015952.SGD","IE00BD6J9T35.USD","LU0274383008.USD","BK1594","01211","LU2097828714.EUR","BK1589","002594"],"gpt_icon":0},{"id":"2516572154","title":"醫院邁入AI時代，AI醫療概念再度活躍，低迷醫藥股開啓反彈上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2516572154","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516572154?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 13:49","pubTimestamp":1740980956,"startTime":"0","endTime":"0","summary":" “算法 + 数据 + 临床场景” ","market":"us","thumbnail":"https://img3.gelonghui.com/2540d-c0162675-317d-4688-a53e-e37ef1e7bd88.jpg?guru_height=712&guru_width=1078","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/2540d-c0162675-317d-4688-a53e-e37ef1e7bd88.jpg?guru_height=712&guru_width=1078"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1840005","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["09939","000710","300687","BK0221","BK0081","BK1161","BK0231","BK1574","BK0086","BK0102","BK1515","BK0042","BK0028","BK0139"],"gpt_icon":0},{"id":"2516572532","title":"京東健康－Ｒ(86618)股價上升5.873%，現價 $33.35","url":"https://stock-news.laohu8.com/highlight/detail?id=2516572532","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516572532?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 13:30","pubTimestamp":1740979800,"startTime":"0","endTime":"0","summary":"[上升股]京东健康－Ｒ(86618) 股价在下午01:30比前收市价上升5.873%，现股价为 $33.35。至目前为止，今日最高价为$33.35，而最低价为$32.4。总成交量为1.73万股，总成交金额为 $56.212万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2503033798/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06618","LU0051755006.USD","BK1515","86618","BK1583","BK1142","BK1589","BK1591","LU0456827905.SGD","BK1247","BK1571"],"gpt_icon":0}],"pageSize":16,"totalPage":32,"pageCount":29,"totalSize":502}]}}